Gala vs Wellorithm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Wellorithm beats Gala overall, scoring 7.4/10 vs 7.2/10. Wellorithm is more affordable at $147/mo vs $149/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side comparison of Gala and Wellorithm covering pricing, scores, medication types, insurance, and more to help you decide.

Gala

#40 of 49

7.2/10

Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

Higher Rated

Wellorithm

#30 of 49

7.4/10

Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.

Visit Wellorithm

Feature	Gala	Wellorithm
Our Score	7.2/10	7.4/10
Starting Price	$149/mo	$147/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging	Cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers
Ranking	#40	#30

Pros & Cons Compared

Gala

Pros

+Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
−Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
−Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Wellorithm

Pros

+Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats — semaglutide and tirzepatide each in two formats — broader format menu than most compounded-only platforms
+10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
+Competitive entry pricing — $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
+2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
+23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment — verify on independent third-party sources before relying on it)
+Spring promotion advertised at $147 with free shipping included

Cons

−Founding year, corporate ownership, and named prescribers are NOT publicly disclosed — the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients
−49 states only — service is unavailable in Louisiana and outside the United States
−28-day recurring billing cycle with payments non-refundable once processed — strict cancellation policy and no proration for partial months
−Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
−Weight-loss guarantee terms are restrictive: requires verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval — only fees actually paid are refundable, baseline payments remain non-refundable
−Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) with different funnel structures suggest the platform tests multiple lead-capture flows, which can create inconsistent post-click experiences

Our Verdict

Wellorithm edges out Gala with a score of 7.4/10 vs 7.2/10. If budget is your priority, Wellorithm starts at $147/mo compared to Gala's $149/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Gala nor Wellorithm feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review